Cancer groups back California Prop 38 research ballot measure

A coalition of major cancer advocacy organizations is supporting California’s Proposition 38, a November ballot measure aimed at expanding funding for immunology research and future cures. Supporters say the proposal could speed medical breakthroughs as federal research uncertainty threatens clinical trials and lab work.

Why it matters: - Proposition 38 would direct billions of dollars toward cancer and immunology research in California. - Supporters say the measure could help speed treatments and cures for patients facing prostate, lung, blood, colorectal, liver, kidney, bladder, melanoma and other cancers. - The ballot measure is designed to create a steadier funding stream at a time when research budgets are under pressure.

What happened: - Leading cancer advocacy organizations announced support for YES on Prop 38, the California Immunology Research & Cures Initiative on the November ballot. - The coalition includes Prostate Cancer Foundation, Blood Cancer United, GO2 for Lung Cancer, Melanoma Research Alliance, FORCE: Facing Our Risk of Cancer Empowered, International Myeloma Foundation, Kidney Cancer Association, Bladder Cancer Advocacy Network, Liver Coalition, Head and Neck Cancer Alliance, California Colorectal Cancer Coalition and City of Hope. - Lila Javan, an immunotherapy patient and cancer survivor, said years of scientific research transformed her outlook and gave her more time.

The details: - Immunotherapies use the body’s immune system to recognize and stop disease. - Breakthrough immunotherapies are already helping patients with melanoma, lung cancer, leukemia and lymphoma. - The measure would set aside half of its $8.4 billion for competitive grants at California universities and nonprofit research institutions. - The other half would support a nonprofit immunology institute affiliated with the University of California. - The institute would bring together scientists, technology, laboratories, patients and clinical trials. - The California Department of Public Health would select an eligible institute using strict criteria. - The initiative requires grantees to collaborate so discoveries, expertise and best practices are shared across institutions. - Prop 38 caps state administrative costs at 2%. - Spending would be subject to public disclosure and independent financial audits. - Funding could go only to eligible California universities and nonprofit medical research institutions, not pharmaceutical companies or other for-profit corporations.

Between the lines: - The campaign is framing Prop 38 as a response to federal research cuts and uncertainty. - Blood Cancer United said the measure would create a stable source of funding for scientists and medical experts. - The structure suggests an effort to pair basic research with a translation pathway that can move discoveries into clinical use. - The accountability rules appear designed to address voter concerns about how public money is spent.

What's next: - California voters will decide Prop 38 in November. - Supporters say they will continue building the coalition and promoting the measure through YESon38.com. - If approved, the initiative would launch a statewide research funding network and immunology institute focused on life-saving treatments and cures.

The bottom line: - Backers are asking voters to fund a large, tightly controlled research program they say could accelerate cancer breakthroughs and reduce dependence on uncertain federal support.